Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: SRTS

Sensus Healthcare, Inc.

Healthcare | Medical - Devices
$2.81
Market Cap$50M
Volume698
EPS (TTM)$-0.94

Sensus Healthcare, Inc. (NASDAQ: SRTS) is a $50M medical - devices company trading at $2.81. Figures from SEC EDGAR and market feeds; updated 2026-10-11 00:46 UTC.

What Sensus Healthcare, Inc. does

Sensus Healthcare is a medical device company that manufactures and deploys superficial radiation therapy (SRT) systems to treat non-melanoma skin cancer and keloid scars without surgery. The company's core technology is incorporated into a portfolio of devices—the SRT-100, SRT-100+, and SRT-100 Vision—which have been used to treat patients around the world. Beyond device sales, Sensus offers service programs including the Sentinel service program for system maintenance and the Fair Deal Agreement, a revenue-sharing model where the company provides equipment and staff to dermatology clinics.

Summarized from Sensus Healthcare, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Quote
Price$2.81
Market cap$50M
Volume698 shares
Valuation
EPS (TTM)$-0.94
Price/book1.04×

Revenue, margins & earnings

FY2021 Net income: $4MFY2021 Operating expenses: $13MFY2021 Cost of revenue: $10M$27MFY2021FY2022 Revenue: $45M — margin split not shown (non-operating gains)$45MFY2022FY2023 Revenue: $24M — margin split not shown (non-operating gains)$24MFY2023FY2024 Net income: $7MFY2024 Taxes & interest: $1MFY2024 Operating expenses: $16MFY2024 Cost of revenue: $17M$42MFY2024FY2025: net loss $8M on revenue $27M$27MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-08-31
  • 2026-08-31DirectorPurchase27,304$96.6K
  • 2026-08-31DirectorPurchase37,537$129.0K
  • 2026-08-28DirectorPurchase9,708$31.9K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Sensus Healthcare, Inc. do?

Sensus Healthcare is a medical device company that manufactures and deploys superficial radiation therapy (SRT) systems to treat non-melanoma skin cancer and keloid scars without surgery.

What is SRTS's valuation?

SRTS trades at $2.81, as of 2026-10-11.

When did SRTS last file with the SEC?

Sensus Healthcare, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-05. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-10-11 00:46 UTC. This page is also available as JSON at /api/data?ticker=SRTS and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for SRTS and 5,000+ tickers.

Create a free account — keep SRTS
For your agent
GET /api/data?ticker=SRTS

This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt